Oncobiologics Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2014
2015
2016
2017
Cash & Short Term Investments
2,349.30
9,071.00
2,351.90
3,185.50
Total Accounts Receivable
-
4,300.10
-
-
Other Current Assets
797.30
1,793.10
3,326.60
719.10
Total Current Assets
3,146.60
15,164.20
5,678.50
3,904.60
Net Property, Plant & Equipment
8,009.60
17,759.90
18,658.60
16,088.90
Total Investments and Advances
211.50
213.70
216.10
-
Other Assets
236.10
1,870.80
852.80
740.40
Total Assets
11,603.70
35,008.60
25,405.90
20,733.90
ST Debt & Current Portion LT Debt
11,482.60
15,819.70
6,176.20
5,006.20
Accounts Payable
3,101.40
11,563.10
5,071.50
10,954.40
Income Tax Payable
1,564.40
1,754.60
1,854.60
2,352.10
Other Current Liabilities
4,061.70
7,904.20
7,334.50
10,425.00
Total Current Liabilities
20,210.10
37,041.60
20,436.90
28,737.70
Long-Term Debt
3,686.00
6,142.10
2,554.50
13,410.90
Other Liabilities
8,154.80
19,377.40
7,587.40
9,311.80
Total Liabilities
32,050.90
62,561.10
30,578.80
51,460.40
Common Equity (Total)
45,151.20
54,219.40
5,172.90
33,651.00
Total Shareholders' Equity
35,773.40
44,028.50
5,172.90
30,726.50
Total Equity
32,672.30
42,979.20
5,172.90
30,726.50
Liabilities & Shareholders' Equity
11,603.70
35,008.60
25,405.90
20,733.90
Accumulated Minority Interest
3,101.00
1,049.40
-
-
Non-Equity Reserves
12,225.10
15,426.70
-
-
Preferred Stock (Carrying Value)
9,377.90
10,190.90
-
2,924.40
About Oncobiologics
View Profile
